Richtlijn CVRM feb2013 - KNMP

Jamerson 2008
Jamerson K, Weber MA, Bakri GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or
hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428.
Jang 2012 Jang JS, Cho KI, Jin HY, Seo JS, Yang TH, Kim DK, et al. Meta-analysis of Cytochrome P450
2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease
patients of different Ethnic Groups treated with Clopidogrel. Am J cardiol 2012 may 14 (Epub
ahead of print).
Janssen 2010
Janssen SP, Smulders YM, Gerdes VE, Visseren FLJ. Spierklachten door statines: onderschat (stand
van zaken). Ned Tijds voor Geneesk 2010; 154 (30); 1421-5.
John 2002 John JH, Ziebland S, Yudkin D, Roe LS, Neil HAW, the Oxford Fruit and Vegetable Study
Group. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and
pressure: a randomized controlled trial. Lancet 2002; 359: 1969-1974.
blood
Josan 2008 Josan K, Majumdar SR, McAlister FA. The Efficacy and safety of intensive statin therapy: a
meta-analysis of randomized trials. CMAJ 2008; 178 (5): 576-84 .
Joy 2009a Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med 2009; 150:
858–868.
Joy 2009 b Joy TR and R.A. Hegele RA. Alternate day dosing of rosuvastatin: potential usefulness in
statin-intolerant patients [comment on Can J Cardiol 2009;25:e28-31]. Can J Cardiol 2009; 25: 453.
Julius 2004
Jun 2010
Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive
patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the
VALUE randomised trial. VALUE trial group. Lancet. 2004;363:2022-31.
Jun M, Foot C, lv J, Neal B, Patel A, Nicholls SJ, et al. Effects of fibrates on cardiovascular
outcomes: a systematic review and meta-analysis. Lancet 2010; 375: 1875-84.
Kaatz 2012 Kaatz S, Kouides PA, Garcia DA, Spyropoulos AC, Crowther M, Douketis JD. Guidance on the
emergent reversal of oral thrombin and factor Xa inhibitors. Am J of Hematology 2012; 87:
141-145.
Kakkar 2008 Kakkar AK, Brenner B, Dahl OE, Eriksson BI, Mouret P, Muntz J, et al. Extended duration
rivaroxaban versus short-term enoxaparin fot the prevention of venouw thromboembolism
Total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008; 372 (9632): 31-9.
afer
Kastelein 2008 Kastelein JJ, Akdim F, Stroes ES et al. Simvastatin wit hor without ezetimibe in familial
hypercholesterolemia. N Eng J Med 2008; 358 ( 14): 1431-43.
Kerkhof vd 2010 Van de Kerkhof RM, Godefrooij MB, Wouda PJ, Vening RA, Dinant G-J en Spigt MG.
Cardiometabole risicofactoren opgespoord met preventieconsult. NTvG 2010; 154: 1891-1897.
Kerst 2009 Kerst AJFA, Hartaanval door calcium Geneesmiddelenbulletin 2009 (43) 33-34).
Kerst 2010 Kerst AJFA, Calcium en myocardinfarct, een meta-analyse. Geneesmiddelen 2010 (44) 143-
144.
Kerst 2011 Kerst AJFA. Werken B-vitaminen en omega-3-vetzuren gunstig bij cardiovasculaire
aandoeningen Geneesmiddelenbulletin 2011; 45: 94-95.
Khan 2006
Khan N, McAlister FA. Re-examining the efficacy of β blockers for the treatment of hypertension: a
meta-analysis. CMAJ 2006;174:1737-42.
Kshirsagar 2005 Kshirsagar AV, Shoham DA, Bang H, Hogan SL, Simpson RJ Jr, Colindres RE. The effect of
cholesterol reduction with cholestyramine on renal function. Am J Kidney Dis. 2005 ;
46(5):812-9.
Klok 2009 Klok T, Sulkers EJ, Kaptein AA, Duiverman EJ, Brand PLP. Therapietrouw bij chronisch zieken.
Patiëntgerichte benadering is noodzakelijk. Ned Tijdschr Geneeskd 2009; 153: 2050-2054.
KNMP2010a KNMP 2010a Farmaceutische Patiëntenzorg, Begeleiding van de patiënt, Therapietrouw.
KNMP-kennisbank augustus 2011.
91
CONCEPT